Advertisement

The Latest

Decision Resources, a pharmaceutical and healthcare research and advisory firm, found therapies to treat chronic back pain and arthritis pain will continue to be the most profitable segments of the chronic pain drug market through 2020, according to a news…

A recent study published in Spine showed that the formation of anti-BMP-2 antibodies is low and transient in spinal fusion patients, and the formation of antibodies doesn't affect fusion rates or have clinical sequelae.

As the trend of physician employment and physician practice acquisition continues at a rapid pace, surgery center physicians are struggling to determine where they will fit in the future of healthcare. They know that surgery centers provide a high-quality service…

Healthcare presents a number of urgent challenges that executives can no longer afford to put off. I was considering what advice to give CEOs facing this brave new world when I heard a remarkable speech at the National Center for…

Researchers at UC Davis announced they will participate in a nationwide study to examine the impact of a single injection of adult stem cells directly into the lumbar disc to repair and regenerate them for patient suffering from chronic low…

Advertisement